Hims & Hers : HIMS

All Hims & Hers Articles

52 Articles

Ian Cooper | Feb 21, 2025 at 11:47 AM EST

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is…

Gerelyn Terzo | Feb 19, 2025 at 11:38 AM EST

Live Markets: S&P 500 Reverses, NKLA Reels, HIMS Soars

The markets are trading lower with the S&P 500 retreating from its recently minted record high levels while the negative…

Joel South | Feb 7, 2025 at 12:53 PM EST

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today

Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating…

Rich Duprey | Jan 15, 2025 at 9:06 AM EST

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly…

Eric Bleeker | Jan 6, 2025 at 9:17 AM EST

Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally

Stocks are running in premarket trading on Monday. Here’s a look at major indexes as of 8:50 a.m. ET: Nasdaq…

Rich Duprey | Sep 3, 2024 at 4:37 PM EDT

Has Eli Lilly Destroyed Hims & Hers Upside?

Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole…

Gerelyn Terzo | Jun 20, 2024 at 5:00 PM EDT

3 Reasons to Buy Hims & Hers Health Stock Now

Summer has officially begun, but some stocks are receiving a chilly reception today. Among them, Hims & Hers Health (NYSE:…

1 2 3 4

Hims & Hers : HIMS

All Hims & Hers Articles

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Live Markets: S&P 500 Reverses, NKLA Reels, HIMS Soars

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally

Has Eli Lilly Destroyed Hims & Hers Upside?

3 Reasons to Buy Hims & Hers Health Stock Now

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Hims & Hers : HIMS

All Hims & Hers Articles

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Live Markets: S&P 500 Reverses, NKLA Reels, HIMS Soars

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Stock Market Today: Nasdaq Composite Up Big as NVIDIA and AI Stocks Rally

Has Eli Lilly Destroyed Hims & Hers Upside?

3 Reasons to Buy Hims & Hers Health Stock Now

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)